Results
2744
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,744 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$142.27 | -1.6% | -12.1% | US$352.1b | US$171.66 | PE23.2x | E8.5% | 3.5% | Pharmaceuticals & Biotech | ||
AZN | UK£107.54 | 2.7% | -1.3% | UK£166.7b | UK£142.66 | PE31.7x | E16.9% | 2.2% | Pharmaceuticals & Biotech | ||
HSBA | UK£7.91 | 0.8% | 25.4% | UK£139.6b | UK£8.65 | PB0.9x | E-1.2% | 6.2% | Banks | ||
CBA | AU$159.75 | 4.2% | 42.6% | AU$267.1b | AU$99.32 | PB3.7x | E4.4% | 2.9% | Banks | ||
PFE | US$26.86 | 1.2% | -7.3% | US$153.7b | US$31.78 | PE35.6x | E9.1% | 6.4% | Pharmaceuticals & Biotech | ||
LOW | US$246.89 | 0.04% | 12.1% | US$139.2b | US$282.83 | PE20.4x | E5.9% | 1.9% | Retail | ||
COP | US$101.62 | 2.5% | -8.6% | US$131.5b | US$132.61 | PE13.3x | E2.2% | 3.7% | Energy | ||
BHP | AU$39.27 | -1.7% | -17.9% | AU$199.9b | AU$46.61 | PE15.7x | E5.9% | 6.0% | Materials | ||
TD | CA$77.92 | 1.8% | -4.9% | CA$137.3b | CA$84.36 | PB1.2x | E14.5% | 5.4% | Banks | ||
BREN | Rp10,475.00 | 12.9% | 84.6% | Rp1401.4t | n/a | PE793.8x | n/a | 0.04% | Utilities | ||
INVE A | SEK 300.30 | 2.8% | 32.5% | SEK 920.0b | SEK 303.50 | PE4.5x | E-55.0% | 1.6% | Diversified Financials | ||
BP. | UK£4.20 | 7.0% | -7.9% | UK£65.7b | UK£4.98 | PE29.9x | E24.1% | 6.0% | Energy | ||
1299 | HK$53.80 | -4.4% | -13.9% | HK$578.9b | HK$92.99 | PE15.4x | E13.9% | 3.0% | Insurance | ||
ATCO A | SEK 176.00 | 4.2% | 7.5% | SEK 825.6b | SEK 189.30 | PE29.8x | E7.4% | 1.6% | Capital Goods | ||
NAB | AU$38.36 | 3.0% | 23.9% | AU$118.1b | AU$33.53 | PB1.9x | E2.1% | 4.4% | Banks | ||
ITW | US$247.61 | -2.3% | -2.5% | US$73.4b | US$263.10 | PE21.2x | E1.0% | 2.4% | Capital Goods | ||
WBC | AU$33.16 | 2.3% | 42.7% | AU$114.3b | AU$28.32 | PB1.6x | E-0.03% | 4.6% | Banks | ||
DGE | UK£25.26 | -0.5% | -9.4% | UK£56.1b | UK£27.27 | PE17.9x | E3.6% | 3.3% | Food, Beverage & Tobacco | ||
GSK | UK£13.60 | 1.0% | -13.4% | UK£55.5b | UK£18.16 | PE22.1x | E20.0% | 4.3% | Pharmaceuticals & Biotech | ||
FDX | US$274.90 | -2.3% | 9.6% | US$66.2b | US$325.95 | PE17.1x | E13.4% | 2.0% | Transportation | ||
CNR | CA$147.24 | 0.9% | -11.5% | CA$94.2b | CA$172.86 | PE17x | E4.2% | 2.3% | Transportation | ||
SPG | US$174.69 | 1.4% | 20.7% | US$65.4b | US$186.03 | PB21.3x | E0.6% | 4.8% | Real Estate | ||
CRH | US$92.51 | -0.01% | 33.5% | US$62.6b | US$113.33 | PE18.1x | E9.1% | 1.5% | Materials | ||
CPG | UK£26.63 | 0.04% | 21.9% | UK£45.2b | UK£27.05 | PE39.8x | E14.8% | 1.8% | Consumer Services |